Psychedelic-assisted therapy research
In addition to her clinical work, Dr. St. Pierre is a post-doctoral fellow with the University of British Columbia and the BC Centre on Substance Use.
Her research focuses on the therapeutic potential of psychedelics and cannabis for mental health, with an emphasis on women’s health, trauma, depression, and substance use.
Current research includes:
-
Psilocybin-assisted psychotherapy for opioid tapering in chronic pain
-
Psilocybin for treatment-resistant depression
-
Exploring the role of ketamine-assisted therapy in community care settings
​
Michelle is passionate about integrating research and practice to improve access to safe, evidence-based innovations in mental health care.
Featured Articles
Medical cannabis and mental health: A guided systematic review
This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment.
Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy
This narrative review examines evidence related to the potential for third wave behaviour therapies to serve as adjuncts to psychedelic-assisted therapy.
Psychedelic use and intimate partner violence: The role of emotion regulation
Recent evidence suggests that psychedelic use predicts reduced perpetration of intimate partner violence among men involved in the criminal justice system. However, the extent to which this association generalizes to community samples has not been examined, and potential mechanisms underlying this association have not been directly explored.
